These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9391102)

  • 1. Replacement of Fhit in cancer cells suppresses tumorigenicity.
    Siprashvili Z; Sozzi G; Barnes LD; McCue P; Robinson AK; Eryomin V; Sard L; Tagliabue E; Greco A; Fusetti L; Schwartz G; Pierotti MA; Croce CM; Huebner K
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13771-6. PubMed ID: 9391102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.
    Barnes LD; Garrison PN; Siprashvili Z; Guranowski A; Robinson AK; Ingram SW; Croce CM; Ohta M; Huebner K
    Biochemistry; 1996 Sep; 35(36):11529-35. PubMed ID: 8794732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
    Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
    Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV
    Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of 5',5'-dinucleoside triphosphate catabolism by APH1, a Saccharomyces cerevisiae analog of human FHIT.
    Chen J; Brevet A; Blanquet S; Plateau P
    J Bacteriol; 1998 May; 180(9):2345-9. PubMed ID: 9573184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.
    Zimonjic DB; Druck T; Ohta M; Kastury K; Croce CM; Popescu NC; Huebner K
    Cancer Res; 1997 Mar; 57(6):1166-70. PubMed ID: 9067288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FHITness and cancer.
    Druck T; Berk L; Huebner K
    Oncol Res; 1998; 10(7):341-5. PubMed ID: 10063967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
    Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma.
    Fang JM; Arlt MF; Burgess AC; Dagenais SL; Beer DG; Glover TW
    Genes Chromosomes Cancer; 2001 Mar; 30(3):292-8. PubMed ID: 11170287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of deletions at the FRA3B/FHIT locus in carcinogenesis.
    Huebner K; Druck T; Siprashvili Z; Croce CM; Kovatich A; McCue PA
    Recent Results Cancer Res; 1998; 154():200-15. PubMed ID: 10027001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.
    Ohta M; Inoue H; Cotticelli MG; Kastury K; Baffa R; Palazzo J; Siprashvili Z; Mori M; McCue P; Druck T; Croce CM; Huebner K
    Cell; 1996 Feb; 84(4):587-97. PubMed ID: 8598045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.
    Ishii H; Dumon KR; Vecchione A; Trapasso F; Mimori K; Alder H; Mori M; Sozzi G; Baffa R; Huebner K; Croce CM
    Cancer Res; 2001 Feb; 61(4):1578-84. PubMed ID: 11245468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R
    Genes Chromosomes Cancer; 1997 Sep; 20(1):98-102. PubMed ID: 9290961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of ectogenous FHIT gene on reversing malignant phenotype of human lung adenocarcinoma cells A549].
    Wang Y; Zhuo Q; Qin Y; Yuan S; Sun Z; Wang Y; Chen X; Sun Z; Song Y; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):225-9. PubMed ID: 12048684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells.
    Wu R; Connolly DC; Dunn RL; Cho KR
    J Natl Cancer Inst; 2000 Feb; 92(4):338-44. PubMed ID: 10675384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the FHIT/FRA3B locus in cancer.
    Huebner K; Garrison PN; Barnes LD; Croce CM
    Annu Rev Genet; 1998; 32():7-31. PubMed ID: 9928473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
    Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
    Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
    Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.